Delivery Order SPE2DB20D2014-SPE2DB24FA12N
Award Date 10/18/23
Potential Completion Date 10/19/23
Potential Value $23K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The contract, valued at $5,988.39, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order and has a firm fixed price pricing type. It does not have a set-aside designation, indicating open competition. The award is associated with a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to support the Defense Logistics Agency's (DLA) medical supply needs. The $9,803.90 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 4, 2024, with an ultimate completion date of November 5, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The contract, valued at $3,855.49, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of September 29, 2023, and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The contract, valued at $3,304.72, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical supplier to the federal government. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The $6,821.27 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 15, 2024 and was awarded on August 14, 2024. The contract is not designated with a set-aside requirement, indicating open competition. It is associated with a larger...
- This federal contract award is for the delivery of Dupixent 200 mg/1.14 ml syringes to the Defense Logistics Agency (DLA). The contract, valued at $5,241.37, was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a wide range of medical...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor that is a subsidiary of the parent company Cencora, Inc. The contract, a Delivery Order valued at $13,233.34, has a completion date of March 7, 2024 and uses a Firm Fixed Price pricing type. There is no set-aside designation for this award. Amerisourcebergen holds a significant...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $14,104.83, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm fixed price, and the ultimate completion date is February 23, 2024. Amerisourcebergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the...
- This federal contract award is for the delivery of Dupixent 300 mg/2 ml syringes to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,972.11 and a completion date of March 27, 2024. It is a Firm Fixed Price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award is for the pharmaceutical product Dupixent 300 mg/2 ml syringe, 2 ml, with a ceiling value of $13,531.42. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 23, 2024 and is a delivery order with a firm fixed price pricing type. The contract is not designated as a set-aside and represents an award...